CIK 0001341235
- Non-accelerated filer
- Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $135,400
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$135,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Alfieri Michael Principal Financial Officer | Purchase | +10,000 | $0.65 | $7K | 17,500 |
| 2026-11-11 | DOUGLAS RICHARD Director | Purchase | +200,000 | $0.64 | $129K | 395,000 |
| 2026-06-09 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Miller-Rich Nancy Director | Grant or award · Stock Option (Right to Buy) | +3,318 | 3,318 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +19,909 | 19,909 | ||
| 2026-06-09 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +2,323 | 2,323 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +6,636 | 6,636 | ||
| 2026-06-09 | Phillips Gary M. Director | Grant or award · Stock Option (Right to Buy) | +4,977 | 4,977 | ||
| 2026-06-09 | Clark William D Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Clark William D Director | Grant or award · Stock Option (Right to Buy) | +2,323 | 2,323 | ||
| 2026-06-09 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Walker Neal Director | Grant or award · Stock Option (Right to Buy) | +3,318 | 3,318 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +5,309 | 5,309 | ||
| 2026-06-09 | Bronstein Ben Director | Grant or award · Stock Option (Right to Buy) | +4,977 | 4,977 | ||
| 2026-06-09 | DEPTULA-HICKS DARLENE M Director | Grant or award · Stock Option (Right to Buy) | +84,557 | 84,557 | ||
| 2026-06-09 | DEPTULA-HICKS DARLENE M Director | Grant or award · Stock Option (Right to Buy) | +9,756 | 9,756 | ||
| 2026-06-03 | Brady Todd C President and CEO | Purchase | +250,000 | $1.67 | $418K | 1,721,298 |
Page 1 of 19 · 378 trades